We used data from the Surveillance, Epidemiology, and End Results (SEER) Program to calculate breast cancer incidence trends among this target population over the most recent 20 years and stratified our analyses by race and ethnicity, hormone receptor status, tumor stage, and age at diagnosis. This evidence concerns the gene NR4A1 and breast carcinoma.